Novo Nordisk Chief Scientific Officer Martin Holst Lange discusses the recent clinical trial results of the company’s weight loss obesity shot CagriSema, which delivered less weight...
Eli Lilly Chief Scientific Officer Daniel M. Skovronsky discusses President Donald Trump’s deal to lower the cost of weight loss drugs for Americans. ––– Subscribe to...
On this website we use first or third-party tools that store small files (cookie) on your device. Cookies are normally used to allow the site to run properly (technical cookies), to generate navigation usage reports (statistics cookies) and to suitable advertise our services/products (profiling cookies). We can directly use technical cookies, but you have the right to choose whether or not to enable statistical and profiling cookies. Enabling these cookies, you help us to offer you a better experience.